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Abstract
Lyme borreliosis (LB) is a multisystem disease caused by spirochetes in the Borrelia burgdorferi 
sensu lato (Bbsl) genospecies complex. We previously described a novel Bbsl genospecies (type 
strain MN14-1420T) that causes LB among patients with exposures to ticks in the upper 
midwestern USA. Patients infected with the novel Bbsl genospecies demonstrated higher levels of 
spirochetemia and somewhat differing clinical symptoms as compared with those infected with 
other Bbsl genospecies. The organism was detected from human specimens using PCR, 
microscopy, serology and culture. The taxonomic status was determined using an eight-
housekeeping-gene (uvrA, rplB, recG, pyrG, pepX, clpX, clpA and nifS) multi-locus sequence 
analysis (MLSA) and comparison of 16S rRNA gene, flaB, rrf–rrl, ospC and oppA2 nucleotide 
sequences. Using a system threshold of 98.3% similarity for delineation of Bbsl genospecies by 
MLSA, we demonstrated that the novel species is a member of the Bbsl genospecies complex, 
most closely related to B. burgdorferi sensu stricto (94.7–94.9% similarity). This same species was 
identified in Ixodes scapularis ticks collected in Minnesota and Wisconsin. This novel species, 
Borrelia mayonii sp. nov, is formally described here. The type strain, MN14-1420, is available 
Correspondence Jeannine M. Petersen, nzp0@cdc.gov. 
The GenBank/EMBL/DDBJ accession number for Borrelia mayonii type strain MN14-1420T are KM877342 (uvrA), KM877343 
(rplB), KM877344 (recG), KM877345 (pyrG), KM877346 (pepX), KM877347 (clpX), KM877348 (clpA), KP972469 (nifS), 
KP972468 (16S rRNA), KR154295 (flaB), KR154297 (ospC), KR154296 (rrf–rrl).
A set of supplementary methods and two supplementary tables are available with the online Supplementary Material.
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through the Deutsche Sammlung von Mikroorganismen und Zelkulturen GmbH (DSM 102811) 
and the American Type Culture Collection (ATCC BAA-2743).
Lyme borreliosis (LB) is a multisystem disease caused by spirochetes of the Borrelia 
burgdorferi sensu lato (Bbsl) complex (Steere, 2001; Stanek et al., 2012). It is the most 
common vector-borne disease in temperate regions of the northern hemisphere, causing an 
estimated 300 000 annual cases in the United States and 85 000 annual cases in Europe 
(Lindgren & Jaenson, 2006; Hinckley et al., 2014). To date, 20 Bbsl genospecies have been 
described, with a subset of these considered pathogenic for humans. Whereas Borrelia 
garinii, Borrelia afzelii and Borrelia bavariensis cause the majority of LB cases in Eurasia, 
B. burgdorferi sensu stricto is the predominant cause of LB in the USA (Margos et al., 2013; 
Schotthoefer & Frost, 2015; Stanek et al., 2012). Among humans, LB is characterized by 
tissue localization and low levels of spirochetemia (van Dam et al., 1993; Aguero-Rosenfeld 
et al., 2005; Liveris et al., 2012; Babady et al., 2008). This is in contrast to infection by 
relapsing fever borreliae in which spirochete loads range from 105 to >106 ml−1 of blood 
(Dworkin et al., 2008).
We recently reported the identification of a novel Bbsl genospecies in six patient specimens 
(five blood and one synovial fluid) submitted to the Mayo Clinic laboratory (Rochester, MN, 
USA) for LB testing using a real-time PCR assay that uses hybridization probes and targets 
the oligopeptide permease A2 gene (oppA2) (Pritt et al., 2016). This PCR assay detects and 
differentiates Bbsl genospecies by melting temperature (Tm) analysis (Babady et al., 2008; 
Pritt et al., 2016). The patients were all residents of the upper midwestern USA (Minnesota, 
Wisconsin and North Dakota) and reported tick exposure in Minnesota and Wisconsin 
during 2012–2014. Patients presented with somewhat differing clinical presentations when 
compared with patients infected with B. burgdorferi sensu stricto including diffuse macular 
rash not typical of erythema migrans (EM), nausea or vomiting and symptoms potentially 
consistent with neurological involvement. By oppA2 quantitative PCR and dark-field 
microscopy, the genome and spirochete load, in blood of acutely ill patients, was estimated 
to be approximately 105 ml−1, which is higher than previously reported among patients 
infected with other Bbsl genospecies (Bil-Lula et al., 2015; Liveris et al., 2012). Motile 
spirochetes were cultured from blood of two patients under microaerophilic conditions at 
34 °C in modified Barbour–Stoenner–Kelly (BSK) medium. After freezing at −80 °C, the 
isolates, MN14-1420 and MN14-1539, were transferred to BSK-II (without gelatin) 
(Zückert, 2007) and grown to densities of over 107 spirochetes ml−1.
Nucleic acid of the novel Bbsl genospecies was also detected by oppA2 PCR in Ixodes 
scapularis ticks collected near the approximate sites of possible patient exposures in Barron 
County, Wisconsin and Clearwater County, Minnesota during 2013–2015 and in I. scapularis 
ticks collected in three other counties (Eau Claire County, Wisconsin and Morrison and Pine 
Counties, Minnesota) during 2010–2015 (Table S1, available in the online Supplementary 
Material) (Pritt et al., 2016). Overall, 29 (2.1 %, range 0%–5.2 %) out of 1381 adult and 6 
(1.5 %, range 0%–3.7 %) out of 399 nymphal I. scapularis ticks tested were PCR-positive 
for the atypical Bbsl genospecies (Supplemental Methods, available in the online 
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Supplementary Material). Of the 35 total ticks testing positive for DNA of the novel Bbsl 
genospecies, 13 (37.1 %) were also positive for B. burgdorferi sensu stricto (Table S1).
Sequencing performed on the oppA2 (149 bp) PCR products directly amplified from both 
patients and an I. scapularis tick collected in Wisconsin showed 89–95% similarity to 
genospecies of the Bbsl complex (Pritt et al., 2016). The closest sequence identity for the 
16S rRNA gene (1327 bp), ospC (561 bp), flaB (435 bp) and rrf–rrl (253 bp) sequences from 
the two patient isolates was to genospecies of the Bbsl complex at 99, 85, 97 and 95 %, 
respectively (Pritt et al., 2016). The taxonomic relationship of the atypical Bbsl isolates, 
MN14-1420 and MN14-1539, was determined using an eight-housekeeping-gene multi-
locus sequence analysis (MLSA) (clpA, clpX, nifS, pepX, pyrG, recG, rplB and uvrA) 
developed by Margos and colleagues for delineation of Bbsl genospecies (Margos et al., 
2009, 2010). A genetic-distance analysis using concatenated sequences of the eight MLSA 
loci (4785 nucleotides) demonstrated that the distance to B. burgdorferi sensu stricto 
(~0.051–0.053) and other species of the genus Borrelia (>0.053) exceeded the previously 
determined threshold for species determination (0.017) (Table S2). The MLST sequence 
types (STs) are ST674 for MN14-1420 and ST675 for MN14-1539. By seven-gene MLSA, 
the genospecies of the Bbsl complex detected in I. scapularis ticks was confirmed to be the 
same as that identified in patients (Pritt et al., 2016). Taken together, these analyses reveal a 
distinct genospecies of the Bbsl complex among patients with LB and I. scapularis ticks 
from the upper midwestern USA. Further work is needed to determine the geographic 
distribution of infected humans and ticks. The novel species is named Borrelia mayonii sp. 
nov. in honor of William James Mayo and Charles Horace Mayo, founders of the Mayo 
Clinic, where this novel organism was first discovered.
Description of Borrelia mayonii sp. nov
Borrelia mayonii (ma.yo’ni.i. N.L. gen. n. after William James Mayo and Charles Horace 
Mayo, founders of the Mayo Clinic).
The morphology matches that of previously described species of the genus Borrelia 
(Barbour & Hayes, 1986). Spirochetes can be cultured in vitro under microaerophilic 
conditions (Johnson et al., 1984) using BSK-II medium (without gelatin) (Zückert, 2007). B. 
mayonii can be distinguished from all other Lyme borreliosis-group spirochetes by MLSA 
of eight housekeeping loci (clpA, clpX, nifS, pepX, pyrG, recG, rplB and uvrA) (Margos et 
al., 2010) and by 16S rRNA gene, flaB, oppA2, ospC and rrf–rrl nucleotide sequences. The 
MLST sequence types (STs) are ST674 for MN14-1420 and ST675 for MN14-1539.
The type strain, MN14=1420T, was isolated from a patient exposed to infected ticks in the 
upper midwestern USA (Pritt et al., 2016); it has been deposited in two microbial culture 
collections: ATCC, deposit number ATCC BAA-2743; DSMZ, deposit number DSM 10281. 
The GenBank/EMBL/DDBJ accession number for the type strain of Borrelia mayonii 
(MN14-1420T) are KM877342 (uvrA), KM877343 (rplB), KM877344 (recG), KM877345 
(pyrG), KM877346 (pepX), KM877347 (clpX), KM877348 (clpA), KP972469 (nifS), 
KP972468 (16S rRNA), KR154295 (flaB), KR154297 (ospC) and KR154296 (rrf–rrl). 
MN14-1539 has also been deposited at the ATCC, deposit number ATCC BAA-2744.
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Abbreviations
Bbsl Borrelia burgdorferi sensu lato
CDC Centers for Disease Control and Prevention
LB Lyme borreliosis
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